Esophageal Cancer in Northeastern Iran

StatusCompleted
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

The 50 most recent of 333 record versions are accounted for below. See every version on ClinicalTrials.gov ↗

  1. Re-verified, no change to tracked fields
  2. New version filed on ClinicalTrials.gov
  3. 48 versions Re-verified since Oct 6, 2024, no change to tracked fieldsv284-v331
Background: -Esophageal cancer is the most common cancer in Iran s Golestan Province. Nutritional deficiencies, ethnicity and environmental exposures might contribute to the development of this disease. Objectives: -To better understand the cause of esophageal cancer in Golestan Province and to reduce its occurrence there. Eligibility: -Adults from the Gonbad, Aq-Qala and Kalaleh districts of eastern Golestan Province in Iran. Design: * The study is a collaboration between NIH, the Digestive Disease Research Center of Teheran University of Medical Sciences, and the International Agency for Research on Cancer. * Participants complete a lifestyle questionnaire and food frequency questionnaire. * Samples of participants blood, urine, hair and toenail clippings are obtained.
Trial Details
NCT Number NCT00450788
Lead Sponsor National Cancer Institute (NCI)
Conditions
(from sponsor)		 Esophageal Cancer, GI Disease
Related terms Esophageal Neoplasms
Enrollment 50,045 participants
Start Date
Updated on ClinicalTrials.gov